Contact
Please use this form to send email to PR contact of this press release:
Carbylan Therapeutics Reports Top-Line Results From COR1.1 Clinical Trial of Hydros-TA in Patients With OA of the Knee
TO:
Please use this form to send email to PR contact of this press release:
Carbylan Therapeutics Reports Top-Line Results From COR1.1 Clinical Trial of Hydros-TA in Patients With OA of the Knee
TO: